Inovotion Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $809K

  • Investors
  • 4

Inovotion General Information

Description

Operator of a biotechnology and oncology efficacy development company dedicated to anti-cancer treatment evaluations and early toxicity studies. The company's technology is applicable to preclinical oncology and immuno-oncology drug discovery programs and supports monitoring the growth and metastatic dissemination of human tumor cells, thereby enabling chemists and biologists from companies and universities to validate targets and develop treatments by getting them through in vivo evaluation within their budget.

Contact Information

Website
www.inovotion.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 5 Avenue du Grand Sablon
  • 38700 La Tronche
  • France
+33 04
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5 Avenue du Grand Sablon
  • 38700 La Tronche
  • France
+33 04

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inovotion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Angel (individual) 07-Nov-2017 $809K Completed Generating Revenue
5. Grant 17-Oct-2016 Completed Generating Revenue
4. Angel (individual) 09-Aug-2016 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Angel (individual) Completed Generating Revenue
1. Spin-Off 01-Jan-2014 Completed Generating Revenue
To view Inovotion’s complete valuation and funding history, request access »

Inovotion Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Inovotion’s complete cap table history, request access »

Inovotion Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Inovotion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3118201-A1 Use of an egg grafted with tumor cells in order to study the anti-cancer effectiveness of immune therapies in the absence of immune effector cells other than those in the grafted egg Pending 29-Oct-2018
FR-3087793-B1 Use of an egg transplated with tumor cells to study the anti-cancer effectiveness of immunotherapies, in the absence of immune effective cells other than those of the transplated egg Active 29-Oct-2018
US-20210337775-A1 Use of an egg grafted with tumor cells in order to study the anti-cancer effectiveness of immune therapies in the absence of immune effector cells other than those in the grafted egg Pending 29-Oct-2018
EP-3874028-A1 Use of an egg grafted with tumor cells in order to study the anti-cancer effectiveness of immune therapies in the absence of immune effector cells other than those in the grafted egg Pending 29-Oct-2018
FR-3087793-A1 Use of a graft egg with tumor cells to study the anti-cancer effectiveness of immunotherapies, in the absence of immune effector cells other than those of egg grafts Active 29-Oct-2018 C12N5/0693
To view Inovotion’s complete patent history, request access »

Inovotion Executive Team (1)

Name Title Board Seat
Jean Viallet Ph.D Founder & Chief Executive Officer
To view Inovotion’s complete executive team members history, request access »

Inovotion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inovotion Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angels Santé Angel Group Minority
Horizon 2020 SME Instrument Government
Angelor Angel Group Minority
InnoVentures Lab Accelerator/Incubator Minority
To view Inovotion’s complete investors history, request access »

Ready to get started?

Request a free trial

Inovotion FAQs

  • When was Inovotion founded?

    Inovotion was founded in 2014.

  • Who is the founder of Inovotion?

    Jean Viallet Ph.D is the founder of Inovotion.

  • Who is the CEO of Inovotion?

    Jean Viallet Ph.D is the CEO of Inovotion.

  • Where is Inovotion headquartered?

    Inovotion is headquartered in La Tronche, France.

  • What is the size of Inovotion?

    Inovotion has 18 total employees.

  • What industry is Inovotion in?

    Inovotion’s primary industry is Drug Discovery.

  • Is Inovotion a private or public company?

    Inovotion is a Private company.

  • What is the current valuation of Inovotion?

    The current valuation of Inovotion is .

  • What is Inovotion’s current revenue?

    The current revenue for Inovotion is .

  • How much funding has Inovotion raised over time?

    Inovotion has raised $1.03M.

  • Who are Inovotion’s investors?

    Angels Santé, Horizon 2020 SME Instrument, Angelor, and InnoVentures Lab have invested in Inovotion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »